BetterScholar BetterScholar
10
Role
Title
Level Year L/R
🐜 Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis
28 auth. Deepak A. Rao, M. Gurish, J. Marshall, Kamil Slowikowski, C. Fonseka, Yanyan Liu, L. Donlin, L. Henderson, Kevin Wei, F. Mizoguchi, N. Teslovich, M. Weinblatt, E. Massarotti, J. Coblyn, S. Helfgott, ... Yvonne C. Lee, D. Todd, V. Bykerk, S. Goodman, A. Pernis, L. Ivashkiv, E. Karlson, P. Nigrovic, A. Filer, C. Buckley, J. Lederer, S. Raychaudhuri, M. Brenner
9 2017
9
🐜
🐜 Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis.
9 auth. M. Weinblatt, J. Kremer, J. Coblyn, A. Maier, S. Helfgott, Martin Morrell, ... Vilma M. Byrne, Mari V. Kaymakcian, V. Strand
8 1999
8
🐜
🐜 Mixed-effects association of single cells identifies an expanded effector CD4+ T cell subset in rheumatoid arthritis
20 auth. C. Fonseka, Deepak A. Rao, N. Teslovich, I. Korsunsky, S. Hannes, Kamil Slowikowski, M. Gurish, L. Donlin, J. Lederer, M. Weinblatt, ... E. Massarotti, J. Coblyn, S. Helfgott, D. Todd, V. Bykerk, E. Karlson, J. Ermann, Yvonne C. Lee, M. Brenner, S. Raychaudhuri
7 2018
7
🐜
🐜 The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study
10 auth. Yvonne C. Lee, L. Chibnik, B. Lu, A. Wasan, R. Edwards, A. Fossel, ... S. Helfgott, D. Solomon, D. Clauw, E. Karlson
7 2009
7
🐜
🦁 Diclofenac-associated hepatotoxicity.
S. Helfgott, J. Sandberg-Cook, D. Zakim, J. Nestler
6 1990
6
🦁
🐬 Emerging therapies for systemic lupus erythematosus--focus on targeting interferon-alpha.
Eben I. Lichtman, S. Helfgott, M. Kriegel
6 2012
6
🐬
🐜 Analysis of pulmonary features and treatment approaches in the COPA syndrome
18 auth. J. Tsui, O. Estrada, Zimu Deng, Kristin M. Wang, Christopher S. Law, B. Elicker, K. Jones, S. Dell, G. Gudmundsson, S. HansdΓ³ttir, ... S. Helfgott, S. Volpi, M. Gattorno, M. Waterfield, Alice Y. Chan, Sharon A. Chung, B. Ley, A. Shum
6 2018
6
🐜
🦁 Polymyalgia rheumatica in patients with a normal erythrocyte sedimentation rate.
S. Helfgott, Raphael I. Kieval
6 1996
6
🦁
🐜 Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.
9 auth. M. Weinblatt, J. Kremer, J. Coblyn, S. Helfgott, A. Maier, G. Petrillo, ... B. Henson, P. Rubin, R. Sperling
6 1992
6
🐜
🐒 Do the clinical responses and complications following etanercept or infliximab therapy predict similar outcomes with the other tumor necrosis factor-alpha antagonists in patients with rheumatoid arthritis?
Herbert T S Ang, S. Helfgott
6 2003
6
🐒